drugset / Trial / NCT05938088
Mirogabalin for Total Hip Arthroplasty
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The purpose of this study is to confirm the analgesic effect of mirogabalin in patients undergoing unilateral hip arthroplasty.
Timeline
- Start
- 2023-07-20
- Primary completion
- 2025-06-28
- Completion
- 2025-06-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirogabalin | Small molecule | 5 mg | — |